Molina Healthcare, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring at the 2026 Annual Meeting of Stockholders held on May 6, 2026. The report details the election of directors, the approval of executive compensation, the ratification of auditors, and significant amendments to corporate governance documents and equity plans.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Corporate Actions
- Equity Plan Amendment: Stockholders approved an amendment to the 2025 Equity Incentive Plan, increasing the aggregate number of shares authorized for issuance by 1,500,000 to a total of 3,295,000 shares.
- Special Meeting Rights: Stockholders approved an amendment to the Certificate of Incorporation allowing stockholders holding at least 20% of voting power to call a special meeting of stockholders.
- Bylaws Restatement: The Board adopted amended and restated Bylaws effective immediately, incorporating the special meeting provisions and adding requirements for requesting stockholders (e.g., continuous ownership for one year).
- Director Elections: All ten director nominees were elected. Notable voting results included significant "Against" votes for Ronna E. Romney (4,035,124) and Dale B. Wolf (3,479,902).
- Executive Compensation: The advisory vote on executive compensation (Say-on-Pay) was narrowly approved, with 22,459,321 votes for and 20,116,888 votes against.
- Auditor Ratification: Ernst & Young LLP was ratified as the independent registered public accounting firm for 2026.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factor disclosures beyond the procedural requirements for calling special meetings outlined in the new Bylaws.
Investor Verification Checklist
- Verify the impact of the increased equity pool (3,295,000 shares) on potential future dilution.
- Review the full text of the Amended and Restated Bylaws (Exhibit 3.2) to understand the specific procedural hurdles for the new 20% special meeting right.
- Analyze the significant dissenting votes on the Say-on-Pay proposal and the election of specific directors (Romney and Wolf) to gauge shareholder sentiment.
- Confirm the effective date of the Certificate of Amendment filed with the Delaware Secretary of State.